Gray/White Matter Contrast in Parkinson’s Disease
Gray/white matter contrast (GWC) decreases with aging and has been found to be a useful MRI biomarker in Alzheimer’s disease (AD), but its utility in Parkinson’s disease (PD) patients has not been investigated. The aims of the study were to test whether GWC is sensitive to aging changes in PD patien...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Frontiers Media S.A.
2018-03-01
|
| Цуврал: | Frontiers in Aging Neuroscience |
| Нөхцлүүд: | |
| Онлайн хандалт: | http://journal.frontiersin.org/article/10.3389/fnagi.2018.00089/full |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|